These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23070990)

  • 1. Effect of rheumatologist education on systematic measurements and treatment decisions in rheumatoid arthritis: the metrix study.
    Pope J; Thorne C; Cividino A; Lucas K
    J Rheumatol; 2012 Dec; 39(12):2247-52. PubMed ID: 23070990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of an educational seminar on use of disease activity measurements by rheumatologists in treatment of rheumatoid arthritis.
    Hamburger MI; Hamburger FH; Bergman JM; Epstein A; Brown A
    J Rheumatol; 2009 Mar; 36(3):532-8. PubMed ID: 19208595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice.
    Harrington JT
    J Rheumatol; 2009 May; 36(5):925-9. PubMed ID: 19369466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life and activity of disease in patients with rheumatoid arthritis].
    Prajs K; Fliciński J; Brzosko I; Przepiera-Bedzak H; Ostanek L; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():39-43. PubMed ID: 17471836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of patient knowledge on rheumatoid arthritis in the range of their own disease--preliminary study.
    Pytel A; Wrzosek Z
    Adv Clin Exp Med; 2012; 21(3):343-51. PubMed ID: 23214198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The composite DAS Score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making.
    Lindsay K; Ibrahim G; Sokoll K; Tripathi M; Melsom RD; Helliwell PS
    J Clin Rheumatol; 2009 Aug; 15(5):223-5. PubMed ID: 19590441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.
    Wolfe F; Michaud K; Pincus T; Furst D; Keystone E
    Arthritis Rheum; 2005 Dec; 52(12):3873-9. PubMed ID: 16320335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA).
    Anderson JK; Zimmerman L; Caplan L; Michaud K
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S14-36. PubMed ID: 22588741
    [No Abstract]   [Full Text] [Related]  

  • 14. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.
    Nanji JA; Choi M; Ferrari R; Lyddell C; Russell AS
    J Rheumatol; 2012 Apr; 39(4):707-11. PubMed ID: 22337235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a collective educational program for patients with rheumatoid arthritis: a prospective 12-month randomized controlled trial.
    Giraudet-Le Quintrec JS; Mayoux-Benhamou A; Ravaud P; Champion K; Dernis E; Zerkak D; Ouslimani A; Courpied JP; Revel M; Kahan A; Dougados M
    J Rheumatol; 2007 Aug; 34(8):1684-91. PubMed ID: 17610321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.